Burning Rock Biotech Limited

BNR | NASDAQ

Price Alert Chart Builder DCF Calculator

$14.73

+$0.50 (+3.48%)

At close: Sep 21, 2026, 4:00 PM ET

$14.73

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.48%

(1D)

Rating

Updated: Aug 27, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $15.57M

1D Range

14.47 15.43

52W Range

6.79 41.72

Valuation (TTM)

PE -1.60

PB 0.21

EV/EBITDA 6.36

Valuation (NTM)

Forward PE N/A

Forward PEG -0.04

Price Target N/A

Cash Flow

FCF Yield -16.8%

SBC Adj. FCF Yield -25.2%

SBC Impact -50.1%

Margins

Gross Margin 74.5%

Operating Margin -13.0%

FCF Margin -3.5%

Growth (CAGR)

Revenue 3Y | 5Y -5.1% | 0.5%

Dil EPS 3Y | 5Y 97.5% | 47.7%

FCF 3Y | 5Y 79.6% | 61.6%

Returns

ROA -9.1%

ROE -13.0%

ROIC -11.7%

Financial Health

Net Cash

¥396.28M ($58.41M)

Current Ratio 3.03

Interest Coverage -1,083.62

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the P...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 667

IPO Date Jun 11, 2020

Website www.brbiotech.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Latest Earnings

Sep 10, 2026

EPS

-$0.20

Beat +91.33%

YoY: -33.33%

REV

$19.87M

Beat +3.48%

YoY: +6.60%

Next Earnings

Nov 17, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞